Genetic Signatures Ltd has released a press release.
CE-IVD received for STI test
Filed with ASX ·
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- Supply agreement with major US customer
- First quarter sales update
- Preliminary Final Report
- Quarterly report and Appendix 4C
- S&P DJI Announces June 2020 Quarterly Rebalance
Later from Genetic Signatures
- Investor update
- 3base SARS-CoV-2 kit registered by TGA for saliva samples
- S&P DJI Announces March 2022 Quarterly Rebalance
- Public Health Wales Awards Enteric Testing Contract to GSS
- Clinical trial recruitment completed for US enteric kit
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures